Harvard Apparatus Regenerative Technology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 351.33 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 39.22K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 7.20K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 141.13K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 408.19K shares, a 39.56% increase from fiscal 2023.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 292.49K shares, a 12.54% decline from fiscal 2022.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 334.42K shares, a 51.27% decline from fiscal 2021.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 686.23K shares, a 354.38% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 351.33K shares 10-Q · filed 2026-08-13 | |||||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 292.49K shares 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 292.49K shares 10-Q · filed 2025-08-11 | |||||
| 2024-12-31 | 39.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 46.42K shares derived: sum of 2 quarters · filed 2026-03-19 | 187.55K shares derived: sum of 3 quarters · filed 2026-03-19 | 408.19K shares 10-K · filed 2026-03-19 | ||
| 2024-09-30 | 7.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 148.32K shares derived: sum of 2 quarters · filed 2024-11-13 | 368.96K shares 10-Q · filed 2024-11-13 | -1.46M shares derived: sum of 4 quarters · filed 2026-03-19 | ||
| 2024-06-30 | 141.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 361.77K shares 10-Q · filed 2024-08-13 | -1.47M shares derived: sum of 3 quarters · filed 2026-03-19 | |||
| 2024-03-31 | 220.64K shares 10-Q · filed 2024-05-13 | -1.61M shares derived: sum of 2 quarters · filed 2026-03-19 | ||||
| 2023-12-31 | -1.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 292.49K shares 10-K · filed 2026-03-19 | 2.13M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 2.12M shares 10-Q · filed 2023-11-13 | |||||
| 2022-12-31 | -92.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -92.97K shares derived: sum of 2 quarters · filed 2024-03-28 | 334.42K shares 10-K · filed 2024-03-28 | 427.39K shares 10-K · filed 2023-03-30 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 427.39K shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 427.39K shares 10-Q · filed 2022-08-04 | |||||
| 2021-12-31 | 36.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 536.23K shares derived: sum of 2 quarters · filed 2023-03-30 | 686.23K shares 10-K · filed 2023-03-30 | |||
| 2021-09-30 | 500.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 650.00K shares 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 150.00K shares 10-Q · filed 2021-08-13 | |||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | 0.00 shares derived: sum of 2 quarters · filed 2021-04-13 | 0.00 shares derived: sum of 3 quarters · filed 2021-04-13 | 151.03K shares 10-K · filed 2021-04-13 | ||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-13 | 151.03K shares 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 151.03K shares 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | 151.03K shares 10-Q · filed 2020-05-14 | |||||
| 2018-05-31 | 1.60M shares 10-Q · filed 2018-11-09 | |||||
| 2016-05-31 | 1.60M shares 10-Q · filed 2018-08-14 | |||||
| 2013-09-30 | 217.90K shares 10-Q · filed 2013-11-27 |